Table of Contents
Chapter 1. India Proficiency Testing Landscape Market Overview
1.1. Definition & Scope: PT Market in Clinical Diagnostics
1.2. Types of PT Programs
1.3. India PT Market Structure
1.4. Total Number of Labs in India
1.5. PT Adoption
1.6. Estimated Market Size and Growth Estimates, 2021 to 2033 (USD Million)
1.7. Accreditation Bodies in PT
1.8. Laboratory Spend Analysis: Average PT Cost Per Test
Chapter 2. Mapping and Detailed Profiles of Indian PT Providers
2.1. Company Profiles
2.1.1. NEUBERG ANAND ACADEMY OF LABORATORY MEDICINE
2.1.2. CHRISTIAN MEDICAL COLLEGE VELLORE
2.1.3. FUGEN BIOMED PRIVATE LIMITED
2.1.4. GLOBAL PT PROVIDER PRIVATE LIMITED
2.1.5. TATA MEMORIAL HOSPITAL PT SERVICES
2.1.6. LALPATHLABS.COM
2.1.7. METROPOLIS HEALTHCARE LTD
2.1.8. ISHTM–AIIMS EXTERNAL QUALITY ASSURANCE PROGRAMME (EQAP)
2.1.9. ICMR - NATIONAL INSTITUTE OF TRANSLATION VIROLOGY AND AIDS RESEARCH (NITVAR)
2.1.10. RML PATHALOGY
2.1.11. CHIMERA
2.1.12. PT DIVISION, QUALITY ASSURANCE FORUM, A UNIT OF UNIQAS HEALTHCARE SOLUTION LLP
2.1.13. FARE LABS
2.1.14. AASHVI PT LLP
2.1.15. ENVIROCARE LABS PT CELL
2.2. Comparative Landscape of Indian PT Providers
2.3. Market Share Analysis, by Application
2.4. Market Share Analysis, by End-use
Chapter 3. Proficiency Testing Material Cost, Regulatory Information & Testing Requirements
3.1. PT Material Cost
3.2. Regulatory Information for PT Materials
3.3. Testing Requirements for PT Programs
3.4. PT Material Supplier Landscape (India)
3.5. Supplier–PT Provider Cost Structure & Procurement Models
Chapter 4. Competitive Analysis
4.1. Company Profiles
4.1.1. NEUBERG ANAND ACADEMY OF LABORATORY MEDICINE
4.1.2. CHRISTIAN MEDICAL COLLEGE VELLORE
4.1.3. FUGEN BIOMED PRIVATE LIMITED
4.1.4. GLOBAL PT PROVIDER PRIVATE LIMITED
4.1.5. TATA MEMORIAL HOSPITAL PT SERVICES
4.1.6. LALPATHLABS.COM
4.1.7. METROPOLIS HEALTHCARE LTD
4.1.8. ISHTM–AIIMS EXTERNAL QUALITY ASSURANCE PROGRAMME (EQAP)
4.1.9. ICMR - NATIONAL INSTITUTE OF TRANSLATION VIROLOGY AND AIDS RESEARCH (NITVAR)
Chapter 5. Detailed Profiles of PT Providers Globally
5.1. Company Profiles
5.1.1. UK NEQAS (UNITED KINGDOM NATIONAL EXTERNAL QUALITY ASSESSMENT SERVICE)
5.1.2. EMQN (EUROPEAN MOLECULAR GENETICS QUALITY NETWORK)
5.1.3. GENQA (GENOMICS QUALITY ASSESSMENT)
5.1.4. COLLEGE OF AMERICAN PATHOLOGISTS (CAP)
5.1.5. AMERICAN PROFICIENCY INSTITUTE (API)
5.1.6. BIO-RAD EQAS (EXTERNAL QUALITY ASSURANCE SERVICES)
5.1.7. RCPAQAP (ROYAL COLLEGE OF PATHOLOGISTS OF AUSTRALASIA QUALITY ASSURANCE PROGRAMS)
5.1.8. QCMD (QUALITY CONTROL FOR MOLECULAR DIAGNOSTICS)
5.1.9. INSTAND
5.1.10. CONTROL LAB (QUALITY CONTROL FOR LABORATORIES LTDA
5.1.11. RANDOX INTERNATIONAL QA (RIQAS, RANDOX INTERNATIONAL QUALITY ASSESSMENT SCHEME)
5.1.12. LGC AXOLABS (AXIOS) (LGC LIMITED)
5.1.13. WLSH (UNIVERSITY OF WISCONSIN SYSTEM)
5.2. Comparative Benchmarking of EQA/PT Providers
5.3. Competitors Growth and Operational Strategies
5.4. Sales, Distribution & Channel Strategy of Global PT Providers